MeSH term
Frequency | Condition_Probility | Animals | 102 | 0.0 |
Blotting, Western | 19 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Humans | 260 | 0.0 |
Radioimmunoassay | 7 | 0.0 |
Rats | 37 | 0.0 |
Research Support, Non-U.S. Gov't | 146 | 0.0 |
Cattle | 14 | 0.0 |
Cells, Cultured | 9 | 0.0 |
Chick Embryo | 2 | 0.0 |
Glycosylphosphatidylinositols/metabolism | 2 | 3.0 |
Ligands | 3 | 0.0 |
Mice | 42 | 0.0 |
Myelin Sheath/metabolism | 4 | 19.0 |
Neurites/drug effects/*metabolism | 2 | 50.0 |
Precipitin Tests | 3 | 0.0 |
Protein Binding | 10 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 55 | 0.0 |
Autoantibodies/*immunology | 6 | 2.0 |
Cross Reactions | 12 | 1.0 |
Dogs | 5 | 0.0 |
Female | 75 | 0.0 |
Immunoglobulin G/immunology | 6 | 1.0 |
Immunoglobulin M/immunology | 18 | 13.0 |
Myelin-Associated Glycoprotein/immunology | 9 | 45.0 |
Rats, Inbred Lew | 4 | 1.0 |
Base Sequence | 14 | 0.0 |
Brain-Derived Neurotrophic Factor/pharmacology | 2 | 4.0 |
Molecular Sequence Data | 31 | 0.0 |
Adult | 46 | 0.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
Heterozygote | 2 | 0.0 |
Male | 83 | 0.0 |
Middle Aged | 72 | 0.0 |
Aged | 61 | 0.0 |
Aged, 80 and over | 14 | 0.0 |
B-Lymphocytes/*immunology | 3 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 34 | 0.0 |
Multiple Sclerosis/*immunology | 9 | 8.0 |
Myelin-Associated Glycoprotein/*immunology | 11 | 35.0 |
T-Lymphocytes/*immunology | 4 | 0.0 |
Diagnosis, Differential | 3 | 0.0 |
Globosides/immunology | 8 | 88.0 |
Neural Conduction | 4 | 4.0 |
Peroneal Nerve/physiopathology | 2 | 28.0 |
Predictive Value of Tests | 2 | 0.0 |
Reaction Time | 2 | 1.0 |
Retrospective Studies | 2 | 0.0 |
Sural Nerve/physiopathology | 2 | 20.0 |
Antibody Specificity | 17 | 1.0 |
Comparative Study | 35 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 5 | 0.0 |
*Chromosomes, Human, Pair 19 | 4 | 1.0 |
Escherichia coli/genetics | 2 | 0.0 |
Gene Library | 3 | 0.0 |
Introns | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Antigens, Neoplasm/*immunology | 3 | 1.0 |
Autoantibodies/immunology | 2 | 1.0 |
Globosides/*immunology | 11 | 100.0 |
Neoplasm Proteins/*immunology | 2 | 5.0 |
Paraproteins/*immunology | 3 | 75.0 |
Autoantibodies/*blood | 8 | 2.0 |
Microscopy, Electron | 8 | 0.0 |
Waldenstrom Macroglobulinemia/*complications/immunology | 3 | 100.0 |
Antibodies, Monoclonal/*analysis | 3 | 6.0 |
Autoantibodies/*analysis | 13 | 6.0 |
Chronic Disease | 6 | 0.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
English Abstract | 17 | 0.0 |
Fluorescent Antibody Technique, Indirect | 3 | 0.0 |
Gangliosides/immunology | 2 | 18.0 |
Glycolipids/*immunology | 4 | 25.0 |
Glycoproteins/*immunology | 4 | 5.0 |
Immunoblotting | 5 | 0.0 |
Immunoglobulin G/analysis | 6 | 1.0 |
Immunoglobulin M/*analysis | 7 | 15.0 |
Immunoglobulins, kappa-Chain/analysis | 3 | 14.0 |
Myelin Sheath/immunology | 2 | 11.0 |
Paraproteinemias/*immunology | 9 | 47.0 |
Peripheral Nerves/*immunology | 7 | 70.0 |
Peripheral Nervous System Diseases/*immunology | 15 | 100.0 |
Sensitivity and Specificity | 2 | 0.0 |
Adolescent | 10 | 0.0 |
Antibodies, Monoclonal | 8 | 0.0 |
Drug Resistance, Multiple | 2 | 1.0 |
Phenotype | 6 | 0.0 |
Kinetics | 4 | 0.0 |
Antibodies/*immunology | 3 | 2.0 |
Immune Sera/immunology | 2 | 1.0 |
Immunoglobulin M/*immunology | 24 | 36.0 |
Immunohistochemistry | 17 | 0.0 |
Antibodies/*analysis | 8 | 7.0 |
Gangliosides/*immunology | 2 | 10.0 |
*Immunoglobulin M | 10 | 35.0 |
Myelin Sheath/*pathology/ultrastructure | 3 | 60.0 |
*Myelin-Associated Glycoprotein | 2 | 16.0 |
Sural Nerve/pathology | 3 | 7.0 |
Tremor/etiology | 2 | 66.0 |
Immune System/physiopathology | 2 | 15.0 |
Age Factors | 3 | 0.0 |
Animals, Newborn | 2 | 0.0 |
Axons/*physiology | 2 | 4.0 |
*Disease Models, Animal | 2 | 0.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Infant, Newborn | 5 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Myelin Basic Proteins/metabolism | 5 | 9.0 |
Myelin Proteins/*metabolism | 11 | 55.0 |
Myelin-Associated Glycoprotein/metabolism | 3 | 33.0 |
Oligodendroglia/*metabolism | 3 | 13.0 |
Receptors, Cell Surface/metabolism | 3 | 0.0 |
Time Factors | 8 | 0.0 |
Nervous System Diseases/*immunology | 8 | 50.0 |
Prognosis | 2 | 0.0 |
Sulfoglycosphingolipids/*immunology | 3 | 50.0 |
Electrophysiology | 9 | 2.0 |
Child | 8 | 0.0 |
Child, Preschool | 7 | 0.0 |
Haplorhini | 2 | 0.0 |
Rabbits | 11 | 0.0 |
Myelin-Associated Glycoprotein/analysis | 4 | 80.0 |
Follow-Up Studies | 3 | 0.0 |
Immunoglobulin M/analysis/*immunology | 2 | 100.0 |
Immunoglobulins/analysis/*immunology | 2 | 100.0 |
Treatment Outcome | 5 | 0.0 |
Golgi Apparatus/immunology | 2 | 33.0 |
Prospective Studies | 3 | 0.0 |
Reference Values | 8 | 0.0 |
Biopsy | 4 | 0.0 |
Peripheral Nervous System Diseases/*pathology | 3 | 60.0 |
Genetic Markers | 2 | 0.0 |
Genotype | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Myelin-Associated Glycoprotein/*genetics | 3 | 16.0 |
Amino Acid Sequence | 19 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
DNA, Complementary/analysis | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Mutation | 4 | 0.0 |
Myelin Basic Proteins/analysis | 5 | 18.0 |
Myelin Proteins/*genetics | 3 | 2.0 |
Axons/physiology | 2 | 4.0 |
Disease Models, Animal | 3 | 0.0 |
Mice, Neurologic Mutants | 2 | 1.0 |
Demyelinating Diseases/*immunology | 7 | 46.0 |
Immunoglobulin M/*blood | 4 | 11.0 |
Polyradiculoneuropathy/*immunology | 2 | 28.0 |
Motor Neurons/physiology | 2 | 4.0 |
Chromatography, Thin Layer | 9 | 5.0 |
Demyelinating Diseases/*immunology/therapy | 2 | 66.0 |
In Vitro | 2 | 0.0 |
Myelin-Associated Glycoprotein/*immunology/metabolism | 2 | 66.0 |
Immunoglobulin A/immunology | 2 | 5.0 |
Myelin Proteins/*immunology | 64 | 74.0 |
Glucuronates/*immunology | 2 | 100.0 |
Glucuronic Acid | 3 | 15.0 |
Paraproteinemias/blood/complications/*immunology | 2 | 100.0 |
Glycosylation | 6 | 0.0 |
Transfection | 4 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Brain/metabolism | 2 | 0.0 |
Pregnancy | 3 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Membrane Glycoproteins/*metabolism | 2 | 0.0 |
Receptors, Immunologic/*metabolism | 2 | 1.0 |
Structure-Activity Relationship | 3 | 0.0 |
Brain/*metabolism | 4 | 0.0 |
Carbohydrate Sequence | 5 | 1.0 |
Demyelinating Diseases/immunology | 2 | 40.0 |
Immunoglobulin M/blood | 3 | 2.0 |
Oligosaccharides/chemistry | 2 | 7.0 |
Carbohydrate Conformation | 2 | 1.0 |
Myelin-Associated Glycoprotein/*chemistry/*metabolism | 2 | 100.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Immunoglobulin M/*metabolism | 6 | 17.0 |
Mice, Inbred BALB C/immunology | 2 | 6.0 |
Mice, Inbred C57BL/immunology | 2 | 50.0 |
Myelin Sheath/*physiology | 4 | 13.0 |
Blotting, Northern | 6 | 0.0 |
*DNA Glycosylases | 2 | 2.0 |
O(6)-Methylguanine-DNA Methyltransferase | 2 | 1.0 |
Hamsters | 6 | 0.0 |
Immunoglobulins/*metabolism | 2 | 3.0 |
*Lectins | 3 | 1.0 |
Cats | 11 | 3.0 |
Electrophoresis, Polyacrylamide Gel | 16 | 0.0 |
Guinea Pigs | 4 | 0.0 |
Myelin-Associated Glycoprotein/analysis/*metabolism | 2 | 100.0 |
Species Specificity | 6 | 0.0 |
Paraproteinemias/*pathology | 2 | 33.0 |
Clone Cells | 2 | 0.0 |
Plant Lectins | 2 | 4.0 |
Syndrome | 2 | 0.0 |
Cell Line | 6 | 0.0 |
Fluorescent Antibody Technique | 9 | 0.0 |
Staining and Labeling | 6 | 0.0 |
Pregnancy Trimester, Second | 2 | 0.0 |
*Antibodies, Monoclonal | 2 | 0.0 |
Chickens | 4 | 0.0 |
Epitope Mapping | 2 | 0.0 |
Mice, Inbred BALB C | 6 | 0.0 |
Myelin Sheath/*chemistry | 2 | 33.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Myelin Proteins/immunology | 18 | 69.0 |
Peripheral Nervous System Diseases/*immunology/*physiopathology | 2 | 66.0 |
Immunoelectrophoresis | 2 | 0.0 |
Myelin-Associated Glycoprotein | 120 | 94.0 |
*Chromosome Mapping | 3 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Membrane Glycoproteins/*genetics | 2 | 0.0 |
Antigens/analysis | 2 | 1.0 |
Gene Expression Regulation | 2 | 0.0 |
Mice, Inbred Strains | 3 | 0.0 |
Antigens, CD57 | 5 | 7.0 |
Epitopes | 10 | 1.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Epitopes/immunology | 12 | 2.0 |
Immunoenzyme Techniques | 11 | 0.0 |
Injections | 2 | 1.0 |
Dysgammaglobulinemia/*complications/immunology | 2 | 100.0 |
Immunoglobulin M/analysis | 9 | 4.0 |
Paraproteinemias/*complications/immunology | 4 | 100.0 |
Peripheral Nervous System Diseases/*etiology/immunology | 3 | 100.0 |
Motor Neurons | 2 | 22.0 |
*Neural Conduction | 2 | 10.0 |
Antibodies, Monoclonal/*immunology | 20 | 2.0 |
Peripheral Nervous System Diseases/immunology | 6 | 75.0 |
Antigen-Antibody Reactions | 4 | 1.0 |
Myelin Basic Proteins/immunology | 4 | 4.0 |
Myelin Proteolipid Protein | 3 | 12.0 |
DNA/genetics | 3 | 0.0 |
Chemical Fractionation | 2 | 2.0 |
Fetus | 4 | 0.0 |
Gestational Age | 2 | 0.0 |
Histocytochemistry | 7 | 1.0 |
Lectins | 4 | 4.0 |
Myelin Basic Proteins/*analysis | 3 | 20.0 |
Myelin Sheath/*physiology/ultrastructure | 2 | 40.0 |
Paraproteinemias/*complications | 3 | 50.0 |
Infant | 2 | 0.0 |
Peripheral Nervous System Diseases/*etiology/physiopathology | 2 | 100.0 |
Chromatography, Affinity | 4 | 0.0 |
Lymphocyte Activation | 3 | 0.0 |
Rabbits/immunology | 2 | 2.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 18 | 1.0 |
Peripheral Nerves/*metabolism | 3 | 27.0 |
Peripheral Nervous System Diseases/metabolism | 2 | 33.0 |
*Genes, Immunoglobulin | 2 | 1.0 |
Glycoproteins/immunology | 5 | 5.0 |
Immunoglobulin M/*genetics | 3 | 42.0 |
Immunoglobulin Variable Region/*genetics | 2 | 1.0 |
Myelin Basic Proteins/*immunology | 3 | 1.0 |
Autoantibodies/analysis | 6 | 3.0 |
Autoimmune Diseases/*immunology | 3 | 1.0 |
Multiple Sclerosis/immunology | 3 | 7.0 |
Myasthenia Gravis/immunology | 2 | 28.0 |
Receptors, Cholinergic/immunology | 2 | 11.0 |
Glycolipids/*metabolism | 2 | 6.0 |
Blood Proteins/*analysis | 2 | 1.0 |
Peripheral Nerves/immunology | 3 | 37.0 |
Blood Proteins/*immunology | 2 | 6.0 |
Electromyography | 2 | 1.0 |
Cerebrospinal Fluid/*cytology/immunology | 2 | 66.0 |
Melanoma/*immunology | 2 | 2.0 |
Nervous System Diseases/complications/*immunology | 2 | 100.0 |
Antibodies, Monoclonal/analysis | 3 | 3.0 |
Antigens, Differentiation/*immunology | 3 | 2.0 |
Myelin P0 Protein | 9 | 50.0 |
DNA Probes | 2 | 0.0 |
Nucleic Acid Hybridization | 4 | 0.0 |
Nerve Regeneration/*physiology | 2 | 7.0 |
Oligodendroglia/metabolism | 2 | 4.0 |
Myelin Proteins/metabolism | 4 | 44.0 |
Myelin Sheath/*immunology | 3 | 23.0 |
Brain Chemistry | 8 | 2.0 |
Molecular Weight | 8 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Plasmids | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
Antibodies, Monoclonal/diagnostic use | 5 | 0.0 |
Hypergammaglobulinemia/*immunology | 3 | 33.0 |
Myelin Proteins/analysis/*immunology | 2 | 100.0 |
Immunoglobulin A/analysis | 2 | 1.0 |
Membrane Glycoproteins/immunology | 2 | 1.0 |
Nervous System/*immunology | 3 | 60.0 |
Antibodies, Anti-Idiotypic/*analysis | 2 | 20.0 |
Immunoglobulin Idiotypes/*immunology | 4 | 10.0 |
Peripheral Nervous System Diseases/blood/*immunology | 2 | 100.0 |
Antibodies/*cerebrospinal fluid | 3 | 27.0 |
Antibody Formation | 3 | 0.0 |
Antigens/*immunology | 2 | 2.0 |
Glycosphingolipids/*immunology | 7 | 87.0 |
Paraproteins/immunology | 3 | 100.0 |
*Brain Chemistry | 3 | 1.0 |
Myelin Basic Proteins/*metabolism | 3 | 6.0 |
*Immunoglobulins | 8 | 28.0 |
Antibodies, Monoclonal/*therapeutic use | 2 | 0.0 |
Antilymphocyte Serum/*therapeutic use | 2 | 6.0 |
*Immunosuppression | 2 | 2.0 |
*Kidney Transplantation | 3 | 0.0 |
Myelin Proteins/*physiology | 4 | 80.0 |
Multiple Sclerosis/*cerebrospinal fluid/immunology | 2 | 28.0 |
Antibodies, Anti-Idiotypic/*immunology | 2 | 4.0 |
DNA Restriction Enzymes | 2 | 0.0 |
Hypergammaglobulinemia/immunology | 2 | 16.0 |
*Immunoglobulin M/analysis | 2 | 50.0 |
Demyelinating Diseases/*immunology/pathology | 2 | 50.0 |
Glycolipids/metabolism | 3 | 15.0 |
Carbohydrates/immunology | 2 | 16.0 |
Killer Cells, Natural/immunology | 3 | 0.0 |
Multiple Sclerosis/*metabolism | 4 | 20.0 |
Glial Fibrillary Acidic Protein/analysis | 2 | 1.0 |
Myelin Proteins/*analysis | 8 | 53.0 |
Cell Adhesion Molecules | 6 | 11.0 |
Immunoassay | 2 | 0.0 |
Myelin P2 Protein | 2 | 28.0 |
Myelin Proteins/immunology/*metabolism | 2 | 100.0 |
Cell Adhesion | 2 | 0.0 |
Myelin Proteins/isolation & purification/*metabolism | 2 | 100.0 |
Blood Proteins/*metabolism | 2 | 1.0 |
Epitopes/*analysis | 3 | 1.0 |
Immunologic Techniques | 6 | 1.0 |
Antigens, Differentiation, T-Lymphocyte | 3 | 1.0 |
Antigens, Surface/*immunology | 4 | 2.0 |
Monocytes/*immunology | 2 | 0.0 |
Myelin Sheath/*metabolism | 2 | 5.0 |
Immunochemistry | 5 | 2.0 |
Paraproteinemias/complications/*immunology | 2 | 100.0 |
Nerve Tissue/immunology | 2 | 66.0 |
Antigens, Surface/immunology | 4 | 2.0 |
Immunosorbent Techniques | 4 | 1.0 |
Killer Cells, Natural/*immunology | 6 | 1.0 |
Brain/immunology | 3 | 11.0 |
Epitopes/*immunology | 2 | 0.0 |
Peripheral Nerves/analysis | 3 | 60.0 |
Mice/immunology | 2 | 8.0 |
Paraproteinemias/immunology | 3 | 33.0 |
Glial Fibrillary Acidic Protein/metabolism | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Myelin Sheath/ultrastructure | 3 | 30.0 |
Epitopes/analysis | 3 | 1.0 |
Neurons/immunology | 2 | 33.0 |
Peripheral Nervous System Diseases/*complications/immunology | 2 | 100.0 |
Demyelinating Diseases/*complications/immunology | 2 | 100.0 |
Central Nervous System Diseases/immunology | 2 | 33.0 |
Myelin Sheath/physiology | 4 | 22.0 |
T-Lymphocytes/immunology | 4 | 0.0 |
Staining and Labeling/methods | 2 | 1.0 |
Myelin Proteins/immunology/*isolation & purification | 2 | 100.0 |
Myelin Proteins/analysis | 2 | 22.0 |
Lymphocytes/*immunology | 2 | 0.0 |
Phagocytosis | 2 | 0.0 |
Histological Techniques | 2 | 4.0 |
B-Lymphocytes/immunology | 2 | 0.0 |
Gene Expression Regulation/physiology | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
Myelin-Associated Glycoprotein/*metabolism/pharmacology | 2 | 100.0 |
